Poor Time in Therapeutic Range Control is Associated with Adverse Clinical Outcomes in Patients with Non-Valvular Atrial Fibrillation: A Report from the Nationwide COOL-AF Registry

Krittayaphong et al. (Tue,) studied this question.

www.synapsesocial.com/papers/69d56e1275589c71d767d354 — DOI: https://doi.org/10.3390/jcm9061698

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS· 2016 · 6,435 citations
2. Cost-Effectiveness Analysis of New Oral Anticoagulants Compared To Warfarin In Thai Patients With Non-Valvular Atrial Fibrillation· 2018 · 2 citations
3. The Global Burden of Atrial Fibrillation and Stroke· 2012 · 387 citations
4. 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation· 2019 · 2,181 citations
5. Use of Herbal Medicines by Patients Receiving Warfarin· 2003 · 41 citations